Publication Name	World Journal of Gastroenterology
Manuscript ID	5961
Country	Czech Republic

Received	2013-10-06 18:53
Peer-Review Started	2013-10-08 10:42
To Make the First Decision	2013-10-29 12:33
Return for Revision	2013-10-30 09:43
Revised	2013-11-22 23:16
Second Decision	2014-01-06 18:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-01-06 18:45
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-03-12 13:35
Typeset the Manuscript	2014-03-18 15:24
Publish the Manuscript Online	2014-04-14 10:49

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Colorectal cancer screening: 20 years of development and recent progress
Manuscript Source	Invited Manuscript
All Author List	Miroslav Zavoral, Stepan Suchanek, Ondrej Majek, Premysl Fric, Petra Minarikova, Marek Minarik, Bohumil Seifert and Ladislav Dusek
Funding Agency and Grant Number	Funding Agency Grant Number Intern Grant Agency of the Czech Ministry of Health (IGA) NT 13673-4
Corresponding Author	Miroslav Zavoral, MD, PhD, Professor, Chief, Department of Medicine, 1st Faculty of Medicine, Military University Hospital, Charles University, U Vojenske Nemocnice 1200, Prague 6, CZ 169 02 Prague, Czech Republic. miroslav.zavoral@uvn.cz
Key Words	Colorectal cancer; Population-based screening program; Colonoscopy; Fecal occult blood test
Core Tip	The rising incidence rate of colorectal cancer (CRC) puts demands on systematic approaches towards secondary prevention. The National CRC Screening Program in the Czech Republic has been running for more than 13 years. Nowadays, guaiac and immunochemical fecal occult blood tests (FOBT) are used, as well as screening colonoscopy. The quality control system was devised with the introduction of CRC Screening Registry. Since 2006, 104565 preventive colonoscopies have been performed: 89752 FOBT+ colonoscopies (85.8%) and 14813 screening colonoscopies (14.2%). Adenomas were diagnosed in 30515 patients undergoing FOBT+ colonoscopy (34.0%), and in 3719 patients through screening colonoscopy (25.1%). In all preventive colonoscopies, a total of 4193 cancers were registered.
Publish Date	2014-04-14 10:49
Citation	Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, Seifert B, Dusek L. Colorectal cancer screening: 20 years of development and recent progress. World J Gastroenterol 2014; 20(14): 3825-3834
URL	http://www.wjgnet.com/1007-9327/full/v20/i14/3825.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i14.3825

Full Article (PDF)	WJG-20-3825.pdf
Full Article (Word)	WJG-20-3825.doc
Manuscript File	5961-Review.doc
Answering Reviewers	5961-Answering reviewers.pdf
Copyright License Agreement	5961-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5961-Language certificate.PDF
Peer-review Report	5961-Peer reviews.pdf
Scientific Editor Work List	5961-Scientific editor work list.doc